Zevra Therapeutics (ZVRA) Total Non-Current Liabilities (2014 - 2026)
Zevra Therapeutics' Total Non-Current Liabilities came in at $71.9 million for Q2 2026, down 40.9% from $121.57 million a year earlier but up 9.1% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Total Non-Current Liabilities (2014 - 2026) Analysis & Trends
At the end of FY2025, Zevra Therapeutics' Total Non-Current Liabilities was $120.5 million, down 0.1% from FY2024.
- Total Non-Current Liabilities carries a five-year compound annual growth rate of 9.3% (FY2020 to FY2025).
- Going back by year, Total Non-Current Liabilities was $120.66 million in FY2024 (+27.9%), $94.36 million in FY2023 (+214.4%), $30.02 million in FY2022 (-3.0%) and $30.95 million in FY2021 (-60.0%).
- The five-year range for quarterly Total Non-Current Liabilities is $4.12 million (Q1 2022) to $121.57 million (Q2 2025).
- Year-over-year, Total Non-Current Liabilities has declined for three consecutive quarters, with growth averaging 4.8% over the last eight quarters.
- The fastest year-over-year change in Total Non-Current Liabilities over five years came in Q3 2022 (growth of 409.0%), and the weakest in Q3 2021 (a decline of 93.1%).
- Business Quant data shows ZVRA's Total Non-Current Liabilities at $65.9 million (Q1 2026), $120.5 million (Q4 2025) and $119.49 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 80.25 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 5.92 Bn |
| 10 | Zevra Therapeutics | 650.98 Mn | -161.73 Mn | 38.18 Mn | 71.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 71.90 Mn |
| Mar 31, 2026 | 65.90 Mn |
| Dec 31, 2025 | 120.50 Mn |
| Sep 30, 2025 | 119.49 Mn |
| Jun 30, 2025 | 121.57 Mn |
| Mar 31, 2025 | 115.52 Mn |
| Dec 31, 2024 | 120.66 Mn |
| Sep 30, 2024 | 107.88 Mn |
| Jun 30, 2024 | 104.03 Mn |
| Mar 31, 2024 | 90.93 Mn |
| Dec 31, 2023 | 94.36 Mn |
| Sep 30, 2023 | 77.04 Mn |
| Jun 30, 2023 | 46.33 Mn |
| Mar 31, 2023 | 47.17 Mn |
| Dec 31, 2022 | 30.02 Mn |
| Sep 30, 2022 | 25.72 Mn |
| Jun 30, 2022 | 24.97 Mn |
| Mar 31, 2022 | 4.12 Mn |
| Dec 31, 2021 | 30.95 Mn |
| Sep 30, 2021 | 5.05 Mn |
API Access
Zevra Therapeutics Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();